Prominent circadian absorption of intranasal salmon calcitonin (SCT) in healthy subjects.

In young healthy subjects salmon calcitonin (SCT), intranasally administered, increased in serum as a function of the drug administration time. The serum concentration of a 400 IU SCT dose monitored 10 min after dosing was statistically more significant when inhaled at 0000 than at other, more conventional, administration times (morning or evening). Following dosing at certain times during the day, the serum SCT was less or even questionable with the dose and under the study conditions selected. Dosing without consideration of timing may lead to reduced effect or lack of effect or perhaps ambiguity or controversy regarding the possible circumstance of a "non-absorbent subject". The circadian frequency appears to be a critical determinant of intranasal SCT absorption suggesting administration time to be an important factor in the cost/benefit ratio without the unpleasant side effects sometimes experienced through parenteral routes.

Pepsinogen gastrin mesor ratio: a potential simple marker for gastric secretory function.

As compared to control subjects, patients with duodenal ulcer show decreased levels of serum G and increased levels of serum Group I pepsinogen (PGI). On the other hand, pregnant women in their third trimester show an increased level of serum G and decreased levels of serum PGI. Gastrin stimulates gastric secretion and has a trophic effect on the parietal cells. Concentrations of PGI in serum reflect the capacity of pepsin-secreting cells which are, in turn, closely related to the parietal cell mass. Pepsinogen/G ratio (PGI/G) could represent the effective acid-peptic secretory capacity. This study suggests that for screening and clinical purposes PGI/G ratio provides a good potentially discriminatory marker of gastric secreting capacity reliably correlating and improving the diagnostic significance of single G and/or PGI serum levels.

Toward a medical prolepsis by chronobiology.

Medicine today strongly aims at prevention and optimization of diagnosis and therapy Studies tried staging and standardization of clinical trials in diseases and made search of markers for early diagnosis, prognosis and therapy. Moreover, risk factors and other variables such as predictors are now investigated more often in groups or populations of apparently healthy subjects, especially for such diseases as atherosclerosis and neoplasia. This new aspect of increasing interest may be defined as medical prolepsis (from the Greek pi rho ómicron lambda eta psi iota zeta = anticipated idea). It includes early signals of disease (protopathology) as well as other signals the host shows as defence or alarm reaction. Hence, we suggest a chronobiological approach in this field, which allows to quantify health and reveals more subtle differences in many physiological variables. According to these views, we reported studies concerning humoral markers and other parameters considered as risk factors both in atherosclerosis and in some endocrine tumors.